Advertisement

Genetic variants in dopamine pathways affect personality dimensions displayed by patients with eating disorders

  • Luz M. González
  • Sonia Mota-Zamorano
  • Angustias García-Herráiz
  • Estefanía López-Nevado
  • Guillermo GervasiniEmail author
Original Article
Part of the following topical collections:
  1. Personality and Eating and Weight disorders

Abstract

Purpose

We aimed to analyze the association between common polymorphisms in dopamine pathways with personality dimensions frequently present in patients with eating disorders (ED).

Methods

A total of 324 patients [210 with anorexia nervosa (AN), 80 with bulimia nervosa (BN) and 34 with binge-eating disorder (BED)] were diagnosed according to DSM-5 criteria and interviewed using the EDI 2 and SCL-90R questionnaires at the eating disorders unit. Blood samples were drawn and the DNA screened for polymorphisms in dopamine receptor genes (DRD2 A2/A1 and DRD3 Ser9Gly) and in the dopamine transporter DAT1 10R/9R.

Results

AN patients who carried the DRD3 Gly9Gly genotype displayed significantly higher EDI-2 total scores than patients with the Ser9 allele (118.09 ± 8.75 vs. 97.23 ± 2.73, p = 0.010). In these patients, Gly9Gly carriers also showed higher scores in all the individuals’ EDI-2 scales. Differences were especially relevant for bulimia (p = 0.004), ineffectiveness (p = 0.044), interpersonal distrust (p = 0.037), interoceptive awareness (p = 0.006) and maturity fears (p = 0.038). Epistasis analyses showed a strong effect of the interaction between DRD3 Ser9Gly and DRD2 A2A1 on the bulimia (p < 0.05), ineffectiveness (p < 0.05) and asceticism (p < 0.01) scales, as well as on the EDI-2 total score (p < 0.05). The scores of the SCL-90R inventory were largely unaffected by the presence of the polymorphisms.

Conclusion

Whilst no associations were found for the BN and BED groups, our results suggest that women with AN carrying the homozygous variant Gly9Gly genotype in the dopamine D3 receptor have significantly worse ED-related symptomatology.

Level of evidence

Level III (evidence obtained from well-designed cohort or case–control analytic studies).

Keywords

Eating disorder Anorexia nervosa Bulimia nervosa Binge-eating disorder Dopamine Polymorphism 

Notes

Acknowledgements

This work has been supported in part by Grant GR18007 from Junta de Extremadura, Mérida (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer Europa” and a grant from the Alicia Koplowitz Foundation.

Authors’ contribution

Author GG designed and carried out the study conception. Material preparation was performed by EL-N, data collection was performed by SM-Z and AG-H, data analysis was performed by LMG. The first draft of the manuscript was written by LMG. All authors read and approved the final manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (include name of committee + reference number) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

40519_2019_820_MOESM1_ESM.docx (14 kb)
Supplementary material 1 (DOCX 13 kb)

References

  1. 1.
    Hinney A, Volckmar AL (2013) Genetics of eating disorders. Curr Psychiatry Rep 15:423.  https://doi.org/10.1007/s11920-013-0423-y CrossRefPubMedGoogle Scholar
  2. 2.
    Kontis D, Theochari E (2012) Dopamine in anorexia nervosa: a systematic review. Behav Pharmacol 23:496–515.  https://doi.org/10.1097/FBP.0b013e328357e115 CrossRefPubMedGoogle Scholar
  3. 3.
    Sodersten P, Bergh C, Leon M, Zandian M (2016) Dopamine and anorexia nervosa. Neurosci Biobehav Rev 60:26–30.  https://doi.org/10.1016/j.neubiorev.2015.11.003 CrossRefPubMedGoogle Scholar
  4. 4.
    Broft AI, Berner LA, Martinez D, Walsh BT (2011) Bulimia nervosa and evidence for striatal dopamine dysregulation: a conceptual review. Physiol Behav 104:122–127.  https://doi.org/10.1016/j.physbeh.2011.04.028 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Bello NT, Hajnal A (2010) Dopamine and binge eating behaviors. Pharmacol Biochem Behav 97:25–33.  https://doi.org/10.1016/j.pbb.2010.04.016 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gervasini G, Gonzalez LM, Mota-Zamorano S, Gamero-Villarroel C, Carrillo JA, Flores I, Garcia-Herraiz A (2018) Association of COMT Val158Met polymorphism with psychopathological symptoms in patients with eating disorders. Curr Mol Med 18:65–70.  https://doi.org/10.2174/1566524018666180608090512 CrossRefPubMedGoogle Scholar
  7. 7.
    Collantoni E, Solmi M, Gallicchio D, Santonastaso P, Meneguzzo P, Carvalho AF, Stubbs B, Clementi M, Pinato C, Forzan M, Cassina M, Fontana F, Piva I, Siani R, Salvo P, Tenconi E, Veronese N, Correll CU, Favaro A (2017) Catechol-O-methyltransferase (COMT) Val158Met polymorphism and eating disorders: data from a new biobank and meta-analysis of previously published studies. Eur Eat Disord Rev 25:524–532.  https://doi.org/10.1002/erv.2555 CrossRefPubMedGoogle Scholar
  8. 8.
    Gervasini G, Gonzalez LM, Gamero-Villarroel C, Mota-Zamorano S, Carrillo JA, Flores I, Garcia-Herraiz A (2018) Effect of dopamine receptor D4 (DRD4) haplotypes on general psychopathology in patients with eating disorders. Gene.  https://doi.org/10.1016/j.gene.2018.02.035 CrossRefPubMedGoogle Scholar
  9. 9.
    Bachner-Melman R, Lerer E, Zohar AH, Kremer I, Elizur Y, Nemanov L, Golan M, Blank S, Gritsenko I, Ebstein RP (2007) Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4). Am J Med Genet B Neuropsychiatr Genet 144B:748–756CrossRefGoogle Scholar
  10. 10.
    Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133–139CrossRefGoogle Scholar
  11. 11.
    Laakso A, Pohjalainen T, Bergman J, Kajander J, Haaparanta M, Solin O, Syvalahti E, Hietala J (2005) The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal l-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics 15:387–391CrossRefGoogle Scholar
  12. 12.
    Jeanneteau F, Funalot B, Jankovic J, Deng H, Lagarde JP, Lucotte G, Sokoloff P (2006) A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci USA 103:10753–10758CrossRefGoogle Scholar
  13. 13.
    Gamero-Villarroel C, Gonzalez LM, Gordillo I, Carrillo JA, Garcia-Herraiz A, Flores I, Rodriguez-Lopez R, Gervasini G (2015) Impact of NEGR1 genetic variability on psychological traits of patients with eating disorders. Pharmacogenomics J 15:278–283.  https://doi.org/10.1038/tpj.2014.53 CrossRefPubMedGoogle Scholar
  14. 14.
    Gamero-Villarroel C, Gonzalez LM, Rodriguez-Lopez R, Albuquerque D, Carrillo JA, Garcia-Herraiz A, Flores I, Gervasini G (2017) Influence of TFAP2B and KCTD15 genetic variability on personality dimensions in anorexia and bulimia nervosa. Brain Behav 7:e00784.  https://doi.org/10.1002/brb3.784 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Gamero-Villarroel C, Gordillo I, Carrillo JA, Garcia-Herraiz A, Flores I, Jimenez M, Monge M, Rodriguez-Lopez R, Gervasini G (2014) BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders. Eur Child Adolesc Psychiatry 23:669–679.  https://doi.org/10.1007/s00787-013-0495-6 CrossRefPubMedGoogle Scholar
  16. 16.
    Gamero-Villarroel C, Rodriguez-Lopez R, Jimenez M, Carrillo JA, Garcia-Herraiz A, Albuquerque D, Flores I, Gervasini G (2015) Melanocortin-4 receptor gene variants are not associated with binge-eating behavior in nonobese patients with eating disorders. Psychiatr Genet 25:35–38.  https://doi.org/10.1097/YPG.0000000000000065 CrossRefPubMedGoogle Scholar
  17. 17.
    Gervasini G, Gamero-Villarroel C (2015) Discussing the putative role of obesity-associated genes in the etiopathogenesis of eating disorders. Pharmacogenomics 16:1287–1305.  https://doi.org/10.2217/pgs.15.77 CrossRefPubMedGoogle Scholar
  18. 18.
    Gervasini G, Gordillo I, Garcia-Herraiz A, Flores I, Jimenez M, Monge M, Carrillo JA (2012) Polymorphisms in serotonergic genes and psychopathological traits in eating disorders. J Clin Psychopharmacol 32:426–428.  https://doi.org/10.1097/JCP.0b013e3182539f2b CrossRefPubMedGoogle Scholar
  19. 19.
    Garner D (1991) Eating disorder inventory-2: professional manual. Psychological Assessment Resources, OdessaGoogle Scholar
  20. 20.
    Guimera E, Torrubia R (1987) Adaptación española del “Eating Disorder Inventory Inventory” (EDI) en una muestra de pacientes anoréxicas. Anal Psiquiatr 3:185–190Google Scholar
  21. 21.
    Derogaitis LR (1977) SCL-90-R: administration, scoring and procedures manual. Clinical Psychometrics Research, BaltimoreGoogle Scholar
  22. 22.
    Derogaitis (2002) SCL-90R: cuestinario de 90 síntomas. TEA Ediciones, MadridGoogle Scholar
  23. 23.
    Rytila-Manninen M, Frojd S, Haravuori H, Lindberg N, Marttunen M, Kettunen K, Therman S (2016) Psychometric properties of the Symptom Checklist-90 in adolescent psychiatric inpatients and age- and gender-matched community youth. Child Adolesc Psychiatry Ment Health 10:23.  https://doi.org/10.1186/s13034-016-0111-x CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Dsouza U, Craig I (2008) Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders. Prog Brain Res 172:73–98.  https://doi.org/10.1016/s0079-6123(08)00904-7 CrossRefGoogle Scholar
  25. 25.
    Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X, Moreno V (2007) SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23:644–645.  https://doi.org/10.1093/bioinformatics/btm025 CrossRefPubMedGoogle Scholar
  26. 26.
    Miotto P, Pollini B, Restaneo A, Favaretto G, Sisti D, Rocchi MB, Preti A (2010) Symptoms of psychosis in anorexia and bulimia nervosa. Psychiatry Res 175:237–243.  https://doi.org/10.1016/j.psychres.2009.03.011 CrossRefPubMedGoogle Scholar
  27. 27.
    Martinussen M, Friborg O, Schmierer P, Kaiser S, Overgard KT, Neunhoeffer AL, Martinsen EW, Rosenvinge JH (2017) The comorbidity of personality disorders in eating disorders: a meta-analysis. Eat Weight Disord 22:201–209.  https://doi.org/10.1007/s40519-016-0345-x CrossRefPubMedGoogle Scholar
  28. 28.
    Gazzillo F, Lingiardi V, Peloso A, Giordani S, Vesco S, Zanna V, Filippucci L, Vicari S (2013) Personality subtypes in adolescents with anorexia nervosa. Compr Psychiatry 54:702–712.  https://doi.org/10.1016/j.comppsych.2013.03.006 CrossRefPubMedGoogle Scholar
  29. 29.
    Berkman ND, Lohr KN, Bulik CM (2007) Outcomes of eating disorders: a systematic review of the literature. Int J Eat Disord 40:293–309.  https://doi.org/10.1002/eat.20369 CrossRefPubMedGoogle Scholar
  30. 30.
    Krishnamoorthy S, Rajan R, Banerjee M, Kumar H, Sarma G, Krishnan S, Sarma S, Kishore A (2016) Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson’s disease patients. Parkinsonism Relat Disord 30:13–17.  https://doi.org/10.1016/j.parkreldis.2016.06.005 CrossRefPubMedGoogle Scholar
  31. 31.
    Zhi Y, Yuan Y, Si Q, Wang M, Shen Y, Wang L, Zhang H, Zhang K (2019) The association between DRD3 Ser9Gly polymorphism and depression severity in Parkinson’s disease. Parkinsons Dis 2019:1642087.  https://doi.org/10.1155/2019/1642087 CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Zai CC, Manchia M, Sonderby IE, Yilmaz Z, De Luca V, Tiwari AK, Squassina A, Zai GC, Shaikh SA, Strauss J, King N, Le Foll B, Kaplan AS, Finseth PI, Vaaler AE, Djurovic S, Andreassen OA, Vincent JB, Kennedy JL (2015) Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders. World J Biol Psychiatry 16:171–179.  https://doi.org/10.3109/15622975.2014.953011 CrossRefPubMedGoogle Scholar
  33. 33.
    Huang W, Payne TJ, Ma JZ, Li MD (2008) A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European–American smokers. Am J Med Genet B Neuropsychiatr Genet 147B:1109–1115.  https://doi.org/10.1002/ajmg.b.30731 CrossRefPubMedGoogle Scholar
  34. 34.
    Kang SG, Lee BH, Lee JS, Chai YG, Ko KP, Lee HJ, Han DM, Ji H, Jang GH, Shin HE (2014) DRD3 gene rs6280 polymorphism may be associated with alcohol dependence overall and with Lesch type I alcohol dependence in Koreans. Neuropsychobiology 69:140–146.  https://doi.org/10.1159/000358062 CrossRefPubMedGoogle Scholar
  35. 35.
    Lin CI, Lee SY, Chang YH, Wu JY, Wu YS, Wu PL, Chen HC, Chen SL, Lee IH, Yeh TL, Yang YK, Ko HC, Lu RB (2010) Temperamentsxgenes in bipolar I and bipolar II disorder patients. Psychiatry Res 177:364–366.  https://doi.org/10.1016/j.psychres.2010.03.005 CrossRefPubMedGoogle Scholar
  36. 36.
    Joyce PR, Rogers GR, Miller AL, Mulder RT, Luty SE, Kennedy MA (2003) Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders. Psychiatry Res 119:1–10.  https://doi.org/10.1016/s0165-1781(03)00124-0 CrossRefPubMedGoogle Scholar
  37. 37.
    O’Hara CB, Campbell IC, Schmidt U (2015) A reward-centred model of anorexia nervosa: a focussed narrative review of the neurological and psychophysiological literature. Neurosci Biobehav Rev 52:131–152.  https://doi.org/10.1016/j.neubiorev.2015.02.012 CrossRefPubMedGoogle Scholar
  38. 38.
    Zink CF, Weinberger DR (2010) Cracking the moody brain: the rewards of self starvation. Nat Med 16:1382–1383.  https://doi.org/10.1038/nm1210-1382 CrossRefPubMedGoogle Scholar
  39. 39.
    Black KJ, Hershey T, Koller JM, Videen TO, Mintun MA, Price JL, Perlmutter JS (2002) A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci USA 99:17113–17118.  https://doi.org/10.1073/pnas.012260599 CrossRefPubMedGoogle Scholar
  40. 40.
    Frieling H, Romer KD, Wilhelm J, Hillemacher T, Kornhuber J, de Zwaan M, Jacoby GE, Bleich S (2006) Association of catecholamine-O-methyltransferase and 5-HTTLPR genotype with eating disorder-related behavior and attitudes in females with eating disorders. Psychiatr Genet 16:205–208CrossRefGoogle Scholar
  41. 41.
    Nisoli E, Brunani A, Borgomainerio E, Tonello C, Dioni L, Briscini L, Redaelli G, Molinari E, Cavagnini F, Carruba MO (2007) D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord 12:91–96CrossRefGoogle Scholar
  42. 42.
    Groleau P, Steiger H, Joober R, Bruce KR, Israel M, Badawi G, Zeramdini N, Sycz L (2012) Dopamine-system genes, childhood abuse, and clinical manifestations in women with Bulimia-Spectrum Disorders. J Psychiatr Res 46:1139–1145.  https://doi.org/10.1016/j.jpsychires.2012.05.018 CrossRefPubMedGoogle Scholar
  43. 43.
    Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R (2012) Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci 11:1–24.  https://doi.org/10.1007/7854_2011_169 CrossRefPubMedGoogle Scholar
  44. 44.
    Boraska V, Davis OS, Cherkas LF, Helder SG, Harris J, Krug I, Liao TP, Treasure J, Ntalla I, Karhunen L, Keski-Rahkonen A, Christakopoulou D, Raevuori A, Shin SY, Dedoussis GV, Kaprio J, Soranzo N, Spector TD, Collier DA, Zeggini E (2012) Genome-wide association analysis of eating disorder-related symptoms, behaviors, and personality traits. Am J Med Genet B Neuropsychiatr Genet 159B:803–811.  https://doi.org/10.1002/ajmg.b.32087 CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Flack K, Pankey C, Ufholz K, Johnson L, Roemmich JN (2019) Genetic variations in the dopamine reward system influence exercise reinforcement and tolerance for exercise intensity. Behav Brain Res 375:112148.  https://doi.org/10.1016/j.bbr.2019.112148 CrossRefPubMedGoogle Scholar
  46. 46.
    Gervasini G, Gordillo I, Garcia-Herraiz A, Flores I, Jimenez M, Monge M, Carrillo JA (2013) Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features. J Clin Psychopharmacol.  https://doi.org/10.1097/JCP.0b013e3182970469 CrossRefPubMedGoogle Scholar
  47. 47.
    Hersrud SL, Stoltenberg SF (2009) Epistatic interaction between COMT and DAT1 genes on eating behavior: a pilot study. Eat Behav 10:131–133.  https://doi.org/10.1016/j.eatbeh.2009.01.003 CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Loch AA, van de Bilt MT, Bio DS, Prado CM, de Sousa RT, Valiengo LL, Moreno RA, Zanetti MV, Gattaz WF (2015) Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission. Braz J Psychiatry 37:235–241.  https://doi.org/10.1590/1516-4446-2014-1553 CrossRefPubMedGoogle Scholar
  49. 49.
    Chang YH, Lee SY, Chen SL, Tzeng NS, Wang TY, Lee IH, Chen PS, Huang SY, Yang YK, Ko HC, Lu RB (2013) Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder. J Affect Disord 151:967–972.  https://doi.org/10.1016/j.jad.2013.08.017 CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Lee SY, Chen SL, Chen SH, Chu CH, Chang YH, Lin SH, Huang SY, Tzeng NS, Kuo PH, Lee IH, Yeh TL, Yang YK, Lu RB (2012) Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 39:382–387.  https://doi.org/10.1016/j.pnpbp.2012.07.015 CrossRefPubMedGoogle Scholar
  51. 51.
    Mercader JM, Fernandez-Aranda F, Gratacos M, Ribases M, Badia A, Villarejo C, Solano R, Gonzalez JR, Vallejo J, Estivill X (2007) Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients. Neuropsychobiology 56:185–190.  https://doi.org/10.1159/000120623 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department Medical-Surgical Therapeutics, Medical SchoolUniversity of ExtremaduraBadajozSpain
  2. 2.Eating Disorders UnitInstitute of Mental Disorders, Health Service of ExtremaduraBadajozSpain

Personalised recommendations